Clinical trial
Cystic Fibrosis and Totally Implantable Vascular Access Devices
NCT00244270 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00244270 |
|---|---|
| Title | Cystic Fibrosis and Totally Implantable Vascular Access Devices |
| Official title | Cystic Fibrosis and Totally Implantable Vascular Access Devices: Evaluation of the Incidence of Venous Thrombosis Related to the Catheter and Study of the Genetic and Acquired Risk Factors |
| Acronym | RITHM |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Vaincre la Mucoviscidose |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Venous Thrombosis |
| Intervention type | Device |
| Interventions | totally implantable vascular access device |
| Enrollment | 97 |
| Start date | Dec 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Oct 26, 2005 |
| Last update posted | Aug 29, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: